Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

https://pubmed.ncbi.nlm.nih.gov/33506200/

This experiment tested the effects of Mebendazole on both cancer cells in the laboratory, and on mice with human gliomas attached, and found that the mice given Mebendazole lived significantly longer.

More on Mebendazole

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors

More on Mebendazole

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

Learn More

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Learn More

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors

Learn More

Always Active

Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

Name	Domain	Purpose	Expiry	Type
wpl_user_preference	www.malignantnomore.org	WP GDPR Cookie Consent Preferences	1 year	HTTP
YSC	youtube.com	YouTube session cookie.	Session	HTTP

Marketing

Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Name	Domain	Purpose	Expiry	Type
GPS	youtube.com	Google advertising domain	Session	HTTP
VISITOR_INFO1_LIVE	youtube.com	YouTube cookie.	Session	HTTP

Analytics

Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.

Name	Domain	Purpose	Expiry	Type
_ga	malignantnomore.org	Google Universal Analytics long-time unique user tracking identifier.	2 years	HTTP
_gid	malignantnomore.org	Google Universal Analytics short-time unique user tracking identifier.	1 day	HTTP
_gat_gtag_UA_176823838_1	malignantnomore.org	---	Session	---
IDE	doubleclick.net	Google advertising cookie used for user tracking and ad targeting purposes.	1 day	HTTP

Preferences

Preferences

Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
Unclassified

Unclassified

Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

https://pubmed.ncbi.nlm.nih.gov/33506200/

More on Mebendazole

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors

More on Mebendazole

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors

Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors

Links

Recent Posts

Inhalation of Perillyl Alcohol Formula

Potentiation of Chemotherapy in Brain Tumors by Zinc

Stay in the know

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

More on Mebendazole

More on Mebendazole

Links

Recent Posts

Stay in the know

Cookie Notice